Rohto Pharmaceutical Co.,Ltd.
Rohto Pharmaceutical Co.,Ltd. (RPHCF) Stock Overview
Explore Rohto Pharmaceutical Co.,Ltd.’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
3.4B
P/E Ratio
15.85
EPS (TTM)
$0.98
ROE
0.13%
RPHCF Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Rohto Pharmaceutical Co.,Ltd. (RPHCF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 35.40, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $18.59.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 15.85 and a market capitalization of 3.4B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.